DrugPatentWatch Database Preview
Kaleo Inc Company Profile
Email this page to a colleague
What is the competitive landscape for KALEO INC, and what generic alternatives to KALEO INC drugs are available?
KALEO INC has three approved drugs.
There are thirty-nine US patents protecting KALEO INC drugs.
There are one hundred and forty-five patent family members on KALEO INC drugs in fifteen countries and one supplementary protection certificate in one country.
Summary for Kaleo Inc
| International Patents: | 145 |
| US Patents: | 39 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Kaleo Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-003 | Nov 17, 2017 | RX | Yes | No | 8,016,788 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | 8,939,943 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-002 | Aug 10, 2012 | BX | RX | Yes | Yes | 8,926,594 | ⤷ Try it Free | Y | ⤷ Try it Free | ||
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | 8,627,816 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | 8,206,360 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | 7,731,690 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kaleo Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2008528210 | ⤷ Try it Free |
| Australia | 2017379094 | ⤷ Try it Free |
| United Kingdom | 201315737 | ⤷ Try it Free |
| China | 102076332 | ⤷ Try it Free |
| European Patent Office | 1843812 | ⤷ Try it Free |
| China | 106794431 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kaleo Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | ⤷ Try it Free | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
